Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007

Avalo to receive an approximately $15 million upfront payment, up to $74 million in milestone payments.Apollo to lead continued clinical development of...

Related Keywords

Rockville ,Massachusetts ,United States ,Boston ,Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Ukraine ,Garrya Neil ,Richard Mason ,Christopher Sullivan ,Chris Brinzey ,Kate Burdick ,University College London ,Kings College London ,Avalo Therapeutics Inc ,Apollo Therapeutics Group ,Canale Communications ,Nasdaq ,University Of Cambridge ,Astrazeneca ,Imperial College London ,Apollo Therapeutics Group Limited ,Chief Executive Officer ,Apollo Therapeutics ,Medimmune Limited ,Patient Square Capital ,Rock Springs Capital ,Kings College ,Private Securities Litigation Reform Act ,Avalo Therapeutics ,Rozi Morris ,Nasdaq Avtx ,